Equities Analysts Set Expectations for DENTSPLY SIRONA Inc.’s Q3 2018 Earnings (XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at Northcoast Research reduced their Q3 2018 earnings per share estimates for DENTSPLY SIRONA in a report released on Wednesday. Northcoast Research analyst E. Snyder now expects that the medical instruments supplier will earn $0.77 per share for the quarter, down from their prior forecast of $0.79.

Other analysts have also issued research reports about the company. TheStreet upgraded DENTSPLY SIRONA from a “c” rating to a “b-” rating in a research note on Friday, November 3rd. Stifel Nicolaus reaffirmed a “buy” rating on shares of DENTSPLY SIRONA in a research report on Thursday, October 19th. HC Wainwright reaffirmed a “buy” rating and issued a $68.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, October 3rd. Jefferies Group decreased their target price on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a research report on Wednesday, August 23rd. Finally, Robert W. Baird set a $63.00 target price on DENTSPLY SIRONA and gave the company a “buy” rating in a research report on Thursday, October 19th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company’s stock. DENTSPLY SIRONA has an average rating of “Hold” and a consensus price target of $67.73.

Shares of DENTSPLY SIRONA (NASDAQ XRAY) opened at $66.08 on Friday. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59. The stock has a market capitalization of $15,391.05, a P/E ratio of 26.70, a price-to-earnings-growth ratio of 2.65 and a beta of 1.31. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.66 earnings per share.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Commonwealth Bank of Australia lifted its stake in DENTSPLY SIRONA by 19.0% during the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the last quarter. Acrospire Investment Management LLC bought a new stake in DENTSPLY SIRONA during the second quarter worth $113,000. Dupont Capital Management Corp bought a new stake in DENTSPLY SIRONA during the second quarter worth $116,000. Massey Quick Simon & CO. LLC bought a new stake in DENTSPLY SIRONA during the third quarter worth $124,000. Finally, Korea Investment CORP lifted its stake in DENTSPLY SIRONA by 139.9% during the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after purchasing an additional 1,251 shares during the last quarter. Hedge funds and other institutional investors own 96.59% of the company’s stock.

In related news, CFO Nicholas W. Alexos purchased 50,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, November 13th. The shares were acquired at an average price of $65.85 per share, with a total value of $3,292,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Francis J. Lunger sold 8,900 shares of the stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $65.90, for a total value of $586,510.00. The disclosure for this sale can be found here. Corporate insiders own 1.99% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was reported by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.com-unik.info/2017/12/03/equities-analysts-set-expectations-for-dentsply-sirona-inc-s-q3-2018-earnings-xray.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit